A Composition Comprising Flavonoids And Uses Thereof

Itc Limited
Abandoned App No 3501/CHE/2014 Pharmaceuticals

Patent information

IP India · live record
Application number
3501/CHE/2014
Filing date
16 July 2014
Status
Abandoned
Publication number
10/2016
Publication type
INA
Invention field
Pharmaceuticals

Abstract

The present disclosure relates to a composition comprising flavonoids for maintenance of metabolic health. In particular, the present disclosure relates to a composition comprising myricetin and luteolin. Also provided is a formulation comprising the composition as described.

Applicants

1
India
ITC LIMITED ITC-LIFE SCIENCES AND TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058

Inventors

7
India
SRINIVASAN, YuvarajITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area Phase 1, Bangalore- 560058
India
MIRIYALA, AmarnathITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area Phase 1, Bangalore- 560058
India
SHETTY, Shilpa SachinITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area Phase 1, Bangalore- 560058
India
KAREMPUDI, PavaniITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area Phase 1, Bangalore- 560058
India
DIXIT, Ajay KumarITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area Phase 1, Bangalore- 560058
India
CHAVAN, Milind AbajiITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area Phase 1, Bangalore- 560058
India
CHANDRASEKHARAN, Lakshmanan ChitturITC Limited ITC Life Sciences & Technology Centre #3, 1st Main, Peenya Industrial Area Phase 1, Bangalore- 560058

Specification

Show full textCollapse

CLIAMS:1. A composition comprising a. myricetin; and b. luteolin, wherein said composition enhances metabolic health. 2. The composition as claimed in claim 1, wherein the myricetin to luteolin molar ratio in said composition is in the range of 1:24-24:1. 3. The composition as claimed in claim 2, wherein the myricetin to luteolin molar ratio in said composition is in the range of 1:4-4:1. 4. The composition as claimed in claim 1, wherein the myricetin to luteolin weight ratio in said composition is in the range of 1:22-27:1. 5. The composition as claimed in claim 4, wherein the myricetin to luteolin weight ratio in said composition is in the range of 1:4-5:1. 6. A formulation for oral ingestion comprising of a composition as claimed in claim 1. 7. The formulation as claimed in claim 6, wherein the myricetin and luteolin w/w concentration in said formulation is in the range of 0.001%-0.5%. 8. The formulation as claimed in claim 7, wherein the myricetin and luteolin w/w concentration in said formulation is in the range of 0.001%-0.2%. 9. A method of enhancing metabolic health, said method comprising oral ingestion of a formulation as claimed in claim 6. ,TagSPECI:As Attached

Documents

Sign in to open
Application documents
1 SPEC FOR E-FILING.pdf 23 Jul 2014
2 FORM 5.pdf 23 Jul 2014
3 FORM 3.pdf 23 Jul 2014
4 FIG IN.pdf 23 Jul 2014
5 3501-CHE-2014 POWER OF ATTOREN10-09-2014.pdf 10 Sep 2014
6 3501-CHE-2014 FORM-1 10-09-2014.pdf 10 Sep 2014
7 3501-CHE-2014 CORRESPONDENCE OTHERS 10-09-2014.pdf 10 Sep 2014
8 3501-CHE-2014-FORM 18 [05-06-2018(online)].pdf 05 Jun 2018
9 3501-CHE-2014-FER.pdf 05 Nov 2019
10 3501-CHE-2014-AbandonedLetter.pdf 04 Jul 2026
Search strategy
13501CHE2014searchreport_30-10-2019.pdf